Ceres Inc  

(Public, NASDAQ:CERE)   Watch this stock  
Find more results for CERE
+0.001 (0.18%)
Jul 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.40 - 0.40
52 week 0.16 - 4.80
Open 0.40
Vol / Avg. 0.00/1.31M
Mkt cap 11.10M
P/E     -
Div/yield     -
EPS -1.80
Shares 27.82M
Beta 0.98
Inst. own 24%
Jul 15, 2016
Q3 2016 Ceres Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (May '16) 2015
Net profit margin -106.36% -1035.15%
Operating margin -158.37% -1035.92%
EBITD margin - -1011.76%
Return on average assets - -129.32%
Return on average equity - -176.96%
Employees 44 -
CDP Score - -


1535 Rancho Conejo Blvd
THOUSAND OAKS, CA 91320-1440
United States - Map
+1-805-3766500 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. The Company uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. Its Forage sorghum seeds are used for growing feed for livestock, including dairy and beef cattle. Its technology platforms have application across various end markets, including food, feed, fiber and fuel. It has developed bioinformatics software, Persephone, to deal with the data generated in plant genomics. Its Persephone enables storage and access to datasets, as well as data visualizations to view genetic data from public sources and databases. It markets its seed products under the name Blade. Its customers include dairies and livestock producers, agri-industrial facilities, individual growers and grower cooperatives. It deploys a range of research and development methods and tools.

Officers and directors

Richard William Hamilton Ph.D. President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Paul M. Kuc Chief Financial Officer
Age: 52
Bio & Compensation  - Reuters
Wilfriede van Assche Senior Vice President, General Counsel and Secretary
Age: 60
Bio & Compensation  - Reuters
Roger Pennell Ph.D. Vice President - Trait Development
Age: 55
Bio & Compensation  - Reuters
Cheryl P. Morley Chairman of the Board
Age: 60
Bio & Compensation  - Reuters
Richard Bailey Flavell Ph.D. CBE Director
Age: 72
Bio & Compensation  - Reuters
Aflalo Guimaraes Director
Age: 46
Bio & Compensation  - Reuters
Pascal Brandys Independent Director
Age: 56
Bio & Compensation  - Reuters
Robert Bruce Goldberg Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters